Co-Diagnostics Roars Back With New COVID-19 Test Deal
Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using Co-Diagnostics’ test kit.
All Work
Chris Lange
Why This Analyst Sees 25% More Upside in Apple
Many analysts have said that the market was running hot through August and now may be the time for it to cool off. Despite Tuesday’s pullback, one analyst sees Apple running much higher from…
Sumo Logic Announces Potential Pricing of IPO
Continuous intelligence pioneer Sumo Logic expects to price more than 14 million shares to result in an initial public offering valued up to more than $357 million.
Are More Positive Results on the Way for Kamada’s COVID-19 Pneumonia Treatment?
Kamada has announced initial interim results from its ongoing midstage coronavirus study of its treatment of COVID-19 patients with pneumonia.
Corbus Pharma Suffers Big Setback in Systemic Sclerosis Study
Corbus Pharmaceuticals has reported that its systemic sclerosis study failed to reach the endpoints, and investors were not pleased.
Does Broadcom Deserve More Credit For Q3?
After markets closed Thursday, Broadcom reported fiscal third-quarter earnings per share of $5.40 and revenue of $5.82 billion, compared with consensus estimates of $5.24 in EPS and revenue of $5.76 billion.
Safety Concern Offsets Chronic Kidney Disease Study Positive Results
On Thursday, Akebia Therapeutics Inc. (NASDAQ: AKBA) announced topline results from the Phase 3 PRO2TECT studies evaluating the safety and efficacy of vadadustat in chronic kidney disease (CKD). Shares were crushed afterward. This is…
Auris Medical Makes Key Progress With Midstage Vertigo Trial
Auris Medical has reported topline data from its Phase 2 Travers trial with intranasal betahistine in vertigo.
Are Investors Too Bearish on Conn’s Q2?
Conn’s reported mixed fiscal second-quarter financial results and offered no guidance before the markets opened on Thursday.
Is Cloudera Getting Enough Out of Its Q2 Results and Guidance?
Cloudera top consensus earnings expectations, but the topline guidance disappointed.
CrowdStrike Gets An Earnings Shock in Q2
Cybersecurity firm CrowdStrike posted second-quarter earnings per share (EPS) of $0.03 and $199.0 million in revenue. Consensus estimates had called for a net loss of $0.01 per share and $188.54 million in revenue.
Why One Analyst Is Racing Ahead With a Street-High Target for Peloton
JPMorgan has reiterated its Overweight rating on Peloton and raised the price target to a street-high $105.
DraftKings Dunks on the Competition With Its Newest Teammate
NBA Hall of Fame inductee Michael Jordan will be joining DraftKings as a special advisor to the board of directors.
Why Guess Is Another Retailer Bucking the COVID-19 Trend
Guess reported better than expected fiscal second-quarter financial results before the markets opened on Wednesday.
Why This Gilead Deal Is Huge For Jounce Therapeutics
Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead Sciences Inc. (NASDAQ: GILD). This deal is for the discovery and development of novel…
Will Analysts Ever Catch Up to Zoom Video?
24/7 Wall St. has included some highlights from the Zoom Video Communications earnings report, as well as what analysts are saying about the stock after the fact.
Will This Deal Keep J.Jill Alive?
Like many retailers, J.Jill has been brutalized by the COVID-19 crisis and has drawn down on its credit facilities to stay afloat. An update of its financial situation to investors suggests that things may…
Plus Therapeutics Takes a Big Step in the Fight Against Brain Cancer
Plus Therapeutics shares rallied on Tuesday after an FDA update on its treatment of patients with recurrent glioblastoma.
A Curious Second Vote of Confidence for Eastman Kodak
Eastman Kodak shares jumped on Tuesday after it was disclosed that an investment firm took a sizable stake in the company.
How Zoom Video’s Earnings Are Making the Case For The Best Coronavirus Stock
Zoom Communications reported earnings per share (EPS) of $0.92 and $663.5 million in revenue after markets closed Monday. Consensus estimates had called for $0.45 in EPS and $500.45 million in revenue.